{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T19:11:27Z","timestamp":1718046687533},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.tiv.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T22:16:01Z","timestamp":1414188961000},"page":"1231-1239","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors"],"prefix":"10.1016","volume":"29","author":[{"given":"Robim M.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agapios","family":"Sachinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"De Boe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Rogiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tiv.2014.10.012_b0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Atkinson","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.tiv.2014.10.012_b0010","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/17425255.2013.827170","article-title":"The current status of biomarkers for predicting toxicity","volume":"9","author":"Campion","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2014.10.012_b0015","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1089\/scd.2011.0723","article-title":"Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential","volume":"21","author":"De Kock","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.tiv.2014.10.012_b0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2796.2009.02152.x","article-title":"Human hepatocyte transplantation: state of the art","volume":"266","author":"Fitzpatrick","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tiv.2014.10.012_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on In Vitro hepatocyte models and their applications","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.tiv.2014.10.012_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.tiv.2014.10.012_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/145749691110000103","article-title":"Bridging therapies and liver transplantation in acute liver failure: 10years of MARS experience from Finland","volume":"100","author":"Kantola","year":"2011","journal-title":"Scand. J. Surgery"},{"issue":"4","key":"10.1016\/j.tiv.2014.10.012_b0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/13547500210127318","article-title":"The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis","volume":"7","author":"Kennedy","year":"2002","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.tiv.2014.10.012_b0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2125.2012.04360.x","article-title":"Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?","volume":"75","author":"Kia","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.tiv.2014.10.012_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.tiv.2014.10.012_b0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10408444.2012.682115","article-title":"Organotypic liver culture models: meeting current challenges in toxicity testing","volume":"42","author":"LeCluyse","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.012_b0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11095-005-9045-3","article-title":"Fit-for-purpose method development and validation for successful biomarker measurement","volume":"23","author":"Lee","year":"2006","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.tiv.2014.10.012_b0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/bmm.09.43","article-title":"Genomic and metabolomic advances in the identification of disease and adverse event biomarkers","volume":"3","author":"Mendrick","year":"2009","journal-title":"Biomarkers Med."},{"issue":"11","key":"10.1016\/j.tiv.2014.10.012_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0049611","article-title":"Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling","volume":"7","author":"Nissim","year":"2012","journal-title":"PLoS ONE"},{"issue":"953","key":"10.1016\/j.tiv.2014.10.012_b0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pgmj.2004.026005","article-title":"Acute liver failure","volume":"81","author":"O\u2019Grady","year":"2005","journal-title":"Postgrad. Med. J."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.012_b0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00204-014-1199-5","article-title":"Human stem cell-derived hepatocytes: breakthrough of an expedient tool for preclinical assessment of drug-induced liver injury?","volume":"88","author":"Rodrigues","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.tiv.2014.10.012_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/scd.2013.0157","article-title":"Human skin-derived stem cells as a novel cell source for In Vitro hepatotoxicity screening of pharmaceuticals","volume":"23","author":"Rodrigues","year":"2014","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.tiv.2014.10.012_b0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Current Opin. Hiv Aids"},{"issue":"18","key":"10.1016\/j.tiv.2014.10.012_b0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/15287394.2012.699858","article-title":"Metabonomics biomarkers for subacute toxicit screening for benzene exposure in mice","volume":"75","author":"Sun","year":"2012","journal-title":"J. Toxicol. Environ. Health"},{"issue":"2","key":"10.1016\/j.tiv.2014.10.012_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5966\/sctm.2013-0146","article-title":"Accurate prediction of drug-induced liver injury using stem cell-derived populations","volume":"3","author":"Szkolnicka","year":"2014","journal-title":"Stem Cells Trans. Med."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.012_b0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mnfr.200900169","article-title":"The Japanese toxicogenomics project: application of toxicogenomics","volume":"54","author":"Uehara","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.tiv.2014.10.012_b0110","series-title":"Toxicogenomics: Japanese Initiative Handbook of Toxicogenomics","first-page":"623","author":"Urushidani","year":"2005"},{"issue":"3","key":"10.1016\/j.tiv.2014.10.012_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tiv.2012.01.012","article-title":"Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity","volume":"26","author":"Van Summeren","year":"2012","journal-title":"Toxicol. In Vitro"},{"issue":"1","key":"10.1016\/j.tiv.2014.10.012_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11096-011-9485-2","article-title":"From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics","volume":"33","author":"Wilffert","year":"2011","journal-title":"Int. J. Clin. Pharm."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T07:51:30Z","timestamp":1538121090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0887233314002033"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.10.012","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}